
Date de parution
Contenu texte de l’actualité
Crossject will attend the Invest Securities Biomed Event to present ZENEO® platform and discuss recent clinical success with investors.
Crossject will attend the Invest Securities Biomed Event to present ZENEO® platform and discuss recent clinical success with investors.
Copyright © 2024 CROSSJECT – VERSION BETA TEST